Rituxan and pancytopenia Patient Reports February 09, 2010

Rituxan Side Effects Report #4739014-0
Rituxan side effect was reported by a Physician from UNITED STATES on Nov 05, 2004. Male patient, 81 years of age, weighting 177.9 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia, polyarthritis, serum sickness. Rituxan dosage: 750 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with NEXIUM. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4743992-3
Rituxan side effect was reported by a Physician from UNITED STATES on Nov 05, 2004. Male patient, 81 years of age, weighting 177.9 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia, polyarthritis, serum sickness. Rituxan dosage: 750 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with NEXIUM. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5705632-6
Rituxan side effect was reported by a Physician from UNITED STATES on Apr 07, 2008. Male patient, 79 years of age, was diagnosed with vasculitis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: disease progression, muscle spasms, pain , pancytopenia. Rituxan dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5460686-X
Rituxan side effect was reported by a Consumer or non-health professional from FRANCE on Sept 10, 2007. Male patient was diagnosed with transplant, b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 500 MG, UNK. During the same period patient was treated with PALIFERMIN, ALKERAN, BICNU, CYTARABINE, ETOPOSIDE, ZEVALIN, HEMATOPOETIC PROGENITOR CELLS, GRANOCYTE. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #5299538-7
Rituxan side effect was reported by a Physician from UNITED STATES on Apr 12, 2007. Female patient was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 1000 MG, SINGLE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5304969-2
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Female patient was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, pancytopenia. Rituxan dosage: 1000 MG, SINGLE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5323931-7
Rituxan side effect was reported by a Physician from UNITED STATES on May 10, 2007. Female patient was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, pancytopenia. Rituxan dosage: 1000 MG, SINGLE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5515220-2
Rituxan side effect was reported by a Physician from UNITED STATES on Nov 06, 2007. Female patient was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, pancytopenia. Rituxan dosage: 1000 MG, SINGLE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4740588-4
Rituxan side effect was reported by a Health Professional from UNITED STATES on Oct 14, 2004. Male patient, 79 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 700 MG, UNK, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, CYTOXAN, KYTRIL, DECADRON, BENADRYL, PREDNISONE. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #4728145-7
Rituxan side effect was reported by a Physician from JAPAN on July 15, 2005. Male patient, 78 years of age, weighting 101.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: constipation , neutrophil percentage increased, pancytopenia. Rituxan dosage: 520 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISONE, CELESTAMINE, PYRINAZIN, FUNGIZONE, SELBEX. Patient recovered.

Rituxan Side Effects Report #5443170-9
Rituxan side effect was reported by a Physician from UNITED STATES on Dec 14, 2006. Female patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia, pyrexia. Rituxan dosage: 275 MG/M, SINGLE, INTRAVENOUS. During the same period patient was treated with CENTRUM, IRON SUPPLEMENT. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4739035-8
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2005. Male patient, 65 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: unknown. Patient recovered.

Rituxan Side Effects Report #4661233-2
Rituxan side effect was reported by a Physician from on Apr 26, 2005. Male patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: hepatic function abnormal, pancytopenia. Rituxan dosage: unknown. During the same period patient was treated with CLADRIBINE, MITOXANTRONE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4669462-9
Rituxan side effect was reported by a Physician from on May 09, 2005. Male patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, pancytopenia. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CLADRIBINE, MITOXANTRONE, DEXAMETHASONE, ALLOPURINOL, ROXATIDINE. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #4688446-8
Rituxan side effect was reported by a Physician from on May 23, 2005. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood pressure decreased, chills, pancytopenia, pyrexia, tachycardia. Rituxan dosage: 600 + 570 MG, INTRAVENOUS. During the same period patient was treated with EPIRUBICIN, ETOPOSIDE, VINCRISTINE, CYCLOPHOSPHAMIDE, IBUPROFEN, CHLORPHENIRAMINE MALEATE. Patient recovered.

Rituxan Side Effects Report #4678194-2
Rituxan side effect was reported by a Physician from on May 17, 2005. Female patient, 60 years of age, weighting 114.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 570MG. During the same period patient was treated with ETOPOSIDE, NOVANTRON, FILDESIN, PREDONINE, LOXONIN, POLARAMINE. Patient recovered.

Rituxan Side Effects Report #4682003-5
Rituxan side effect was reported by a Physician from on May 18, 2005. Male patient, 60 years of age, weighting 105.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 560 MG, IV DRIP. During the same period patient was treated with MITOXANTRONE, ETOPOSIDE, CARBOPLATIN, PREDONINE, IBUPROFEN, POLARAMINE, FLUDARA, MITOXANTRONE HYDROCHLORIDE. Patient recovered.

Rituxan Side Effects Report #4714643-9
Rituxan side effect was reported by a Physician from JAPAN on June 28, 2005. Male patient, 60 years of age, weighting 105.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 560 MG, UNK, IV DRIP. During the same period patient was treated with MITOXANTRONE, ETOPOSIDE, CARBOPLATIN, PREDONINE, IBUPROFEN, POLARAMINE, FLUDARA. Patient recovered.

Rituxan Side Effects Report #5035187-3
Rituxan side effect was reported by a Physician from JAPAN on June 20, 2006. Female patient, 60 years of age, weighting 114.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 570 MG. During the same period patient was treated with ETOPOSIDE, NOVANTRONE, FILDESIN, PREDNISOLONE, LOXONIN, POLARAMINE. Patient recovered.


Rituxan Side Effects Report #4688479-1
Rituxan side effect was reported by a Physician from on May 24, 2005. Male patient, 59 years of age, weighting 142.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 640MG, IV DRIP. During the same period patient was treated with ENDOXAN, ADRIACIN, ONCOVIN. Patient recovered.

Rituxan Side Effects Report #4710494-X
Rituxan side effect was reported by a Physician from JAPAN on June 22, 2005. Female patient, 57 years of age, weighting 88.18 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, laboratory test abnormal, pancytopenia, pyrexia. Rituxan dosage: unknown. During the same period patient was treated with PIRARUBICIN HYDROCHLORIDE, ENDOXAN, ONCOVIN, PREDNISOLONE, LOXONIN, POLARAMINE. Patient recovered.

Rituxan Side Effects Report #4745105-0
Rituxan side effect was reported by a Physician from JAPAN on Aug 02, 2005. Female patient, 57 years of age, weighting 88.18 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, pancytopenia, pyrexia. Rituxan dosage: unknown. During the same period patient was treated with THERARUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDONINE, LOXONIN, POLARAMINE. Patient recovered.

Rituxan Side Effects Report #4741994-4
Rituxan side effect was reported by a Physician from UNITED STATES on Aug 04, 2004. Male patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 750 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4779035-5
Rituxan side effect was reported by a Physician from JAPAN on Sept 15, 2005. Female patient, 48 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: c-reactive protein increased, chills, lymphoma , multi-organ failure, neoplasm recurrence, pancytopenia, pyrexia, tachycardia. Rituxan dosage: 525 MG, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, POLARAMINE, METILON, MORPHINE. Patient recovered.


Rituxan Side Effects Report #4678178-4
Rituxan side effect was reported by a Physician from on May 18, 2005. Female patient, 46 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 600 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, ONCOVIN, PREDONINE, ACETAMINOPHEN, DIPHENHYDRAMINE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4708947-3
Rituxan side effect was reported by a Physician from JAPAN on June 29, 2005. Female patient, 46 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, ONCOVIN, PREDONINE, ACETAMINOPHEN, DIPHENHYDRAMINE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4729567-0
Rituxan side effect was reported by a Physician from JAPAN on July 15, 2005. Female patient, 46 years of age, weighting 50.00 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, ONCOVIN, PREDONINE, ACETAMINOPHEN, DIPHENDRAMINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4688449-3
Rituxan side effect was reported by a Physician from on May 24, 2005. Male patient, 33 years of age, weighting 130.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, disease recurrence, infection , neuropathy peripheral, pancytopenia. Rituxan dosage: 630 MG, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, ONCOVIN, ADRIACIN, PREDONINE, CYCLOPHOSPHAMIDE. Patient recovered.

Rituxan Side Effects Report #5035069-7
Rituxan side effect was reported by a Physician from JAPAN on June 20, 2006. Male patient, 33 years of age, weighting 130.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, c-reactive protein increased, haemoglobin decreased, infection , neuropathy peripheral, pancytopenia. Rituxan dosage: 630 MG, UNK, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, ONCOVIN, DOXORUBICIN HYDROCHLORIDE, PREDONINE, CYCLOPHOSPHAMIDE. Patient recovered.


Rituxan Side Effects Report #5443323-X
Rituxan side effect was reported by a Health Professional from UNITED STATES on Jan 03, 2007. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: unknown. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5081556-5
Rituxan side effect was reported by a Physician from UNITED STATES on Aug 02, 2006. Female patient, 75 years of age, was diagnosed with lymphoma  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow toxicity, myelodysplastic syndrome, pancytopenia. Rituxan dosage: unknown. During the same period patient was treated with VINCRISTIINE, CYCLOPHOSPHAMIDE, DOXORUBICIN, LEUKINE, PREDNISONE. Patient recovered.

Rituxan Side Effects Report #5443700-7
Rituxan side effect was reported by a Physician from UNITED STATES on Feb 09, 2007. Male patient, 67 years of age, was diagnosed with lymphoma  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: unknown. During the same period patient was treated with CYTARABINE, CYTOXAN, ETOPOSIDE, STEROIDS, FLUDARABINE, CYCLOPHOSPHAMIDE, MITOXANTRONE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5099125-X
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2005. Male patient, 63 years of age, was diagnosed with lymphoma  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: unknown. During the same period patient was treated with BLOOD TRANSFUSION NOS. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4611625-2
Rituxan side effect was reported by a Physician from on Mar 16, 2005. Male patient, 56 years of age, weighting 145.9 lb, was diagnosed with lymphoma  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: dizziness , fatigue, mucosal inflammation, pancytopenia, weight decreased. Rituxan dosage: 700 MG IV Q3 WEEKS X 8. During the same period patient was treated with CYTOXAN, NOVANTRONE, VINCRISTINE. Patient recovered.


Rituxan Side Effects Report #4855587-1
Rituxan side effect was reported by a Physician from JAPAN on Dec 01, 2005. Female patient, 54 years of age, weighting 109.6 lb, was diagnosed with lymphoma  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow failure, convulsion, hypotension, immunosuppression, multi-organ failure, pancytopenia, pharyngeal oedema, pneumonia bacterial, pseudomonal bacteraemia. Rituxan dosage: 540 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYTARABINE, ETOPOSIDE, DEXAMETHASONE, MORPHINE, RANIDITINE, TEPRENONE. Patient died on 12/24/2001.

Rituxan Side Effects Report #5898019-7
Rituxan side effect was reported by a Physician from UNITED STATES on Sept 17, 2008. Female patient, 49 years of age, was diagnosed with lymphocytic lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, pancytopenia. Rituxan dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient recovered.

Rituxan Side Effects Report #5329372-0
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2007. Female patient, 58 years of age, was diagnosed with graft versus host disease and was treated with Rituxan. After drug was administered, patient experienced the following side effects: febrile neutropenia, pancytopenia, pseudomonas infection. Rituxan dosage: 375 MG/M2, UNK. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5331434-9
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2007. Female patient, 58 years of age, was diagnosed with graft versus host disease, prophylaxis and was treated with Rituxan. After drug was administered, patient experienced the following side effects: febrile neutropenia, pancytopenia, pseudomonas infection. Rituxan dosage: 375 MG/M2, UNK. During the same period patient was treated with ACYCLOVIR, FLUCONAZOLE, MEPRON. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5364250-2
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Female patient, 58 years of age, was diagnosed with graft versus host disease, prophylaxis and was treated with Rituxan. After drug was administered, patient experienced the following side effects: febrile neutropenia, pancytopenia, pseudomonas infection. Rituxan dosage: 375 MG/M2, UNK. During the same period patient was treated with ACYCLOVIR, FLUCONAZOLE, MEPRON. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #5713374-6
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 14, 2008. Female patient, 58 years of age, was diagnosed with graft versus host disease, prophylaxis and was treated with Rituxan. After drug was administered, patient experienced the following side effects: febrile neutropenia, pancytopenia, pseudomonas infection. Rituxan dosage: 375 MG/M2, UNK. During the same period patient was treated with ACYCLOVIR, FLUCONAZOLE, MEPRON. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4847729-9
Rituxan side effect was reported by a Physician from JAPAN on Nov 21, 2005. Male patient, 49 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pancytopenia. Rituxan dosage: 710 MG, INTRAVENOUS. During the same period patient was treated with PIRARUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4868814-1
Rituxan side effect was reported by a Physician from JAPAN on Dec 14, 2005. Male patient, 49 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: deep vein thrombosis , fibrin d dimer increased, pancytopenia. Rituxan dosage: 710 MG, INTRAVENOUS. During the same period patient was treated with PIRARUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4713839-X
Rituxan side effect was reported by a Health Professional from UNITED STATES on June 27, 2005. Male patient, 70 years of age, weighting 224.9 lb, was diagnosed with central nervous system lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemodialysis, pancytopenia, renal failure acute, urinary tract infection . Rituxan dosage: 750 MG, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, LEUCOVORIN CALCIUM, HYZAAR, DECADRON, DILANTIN, ACYCLOVIR, BACTRIM DS, COMPAZINE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4718700-2
Rituxan side effect was reported by a Health Professional from UNITED STATES on July 05, 2005. Male patient, 70 years of age, weighting 224.9 lb, was diagnosed with central nervous system lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: catheter related infection, febrile neutropenia, haemodialysis, pancytopenia, renal failure acute, urinary tract infection . Rituxan dosage: 750 MG, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, LEUCOVORIN CALCIUM, HYZAAR, DECADRON, DILANTIN, ACYCLOVIR, BACTRIM DS, COMPAZINE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4562744-0
Rituxan side effect was reported by a Physician from on Jan 12, 2005. Male patient, 62 years of age, was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: hepatic function abnormal, pancytopenia. Rituxan dosage: 500 MG, SINGLE, INTRAVENOUS. During the same period patient was treated with CLADRIBINE, MITOXANTRONE, DEXAMETHASONE, ZOPICLONE, ROXATIDINE, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4742002-1
Rituxan side effect was reported by a Physician from UNITED STATES on Aug 11, 2004. Male patient, 53 years of age, was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: pancytopenia. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with DEMEROL, HYDROCORTISONE, OXYGEN, BENADRYL, TYLENOL. Patient recovered.

Rituxan Side Effects Report #4778048-7
Rituxan side effect was reported by a Physician from UNITED STATES on Sept 07, 2005. Male patient, 80 years of age, was diagnosed with anaemia haemolytic autoimmune and was treated with Rituxan. After drug was administered, patient experienced the following side effects: kaposi's sarcoma , malignant neoplasm progression, pancytopenia. Rituxan dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with SUPPLEMENTAL OXYGEN. Patient recovered.

Rituxan Side Effects Report #4801397-0
Rituxan side effect was reported by a Physician from UNITED STATES on Sept 28, 2005. Male patient, 80 years of age, was diagnosed with anaemia haemolytic autoimmune and was treated with Rituxan. After drug was administered, patient experienced the following side effects: disease progression, kaposi's sarcoma , pancytopenia. Rituxan dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with SUPPLEMENTAL OXYGEN. Patient recovered.

Rituxan Side Effects Report #5713497-1
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 14, 2008. Male patient was diagnosed with anaemia haemolytic autoimmune and was treated with Rituxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, pancytopenia. Rituxan dosage: unknown. Patient recovered.


Rituxan Side Effects Report #5751339-9
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on May 20, 2008. Male patient was diagnosed with anaemia haemolytic autoimmune and was treated with Rituxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, pancytopenia. Rituxan dosage: unknown. Patient died on 03/09/2008.

Rituxan Side Effects Report #5072727-2
Rituxan side effect was reported by a Health Professional from UNITED STATES on July 21, 2006. Female patient, 75 years of age, was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow toxicity, pancytopenia. Rituxan dosage: unknown. During the same period patient was treated with VINCRISTINE. Patient recovered.

Rituxan Side Effects Report #5500007-7
Rituxan side effect was reported by a Physician from PORTUGAL on Oct 19, 2007. Female patient, 66 years of age, weighting 99.21 lb, was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, bone marrow failure, gamma-glutamyltransferase increased, hypovolaemia, ischaemia, pancytopenia. Rituxan dosage: unknown. During the same period patient was treated with METHOTREXATE, FOLIC ACID, MEDROL, FUROSEMIDE. Patient was hospitalized and became disabled. Patient recovered.

Rituxan Side Effects Report #5501321-1
Rituxan side effect was reported by a Physician from PORTUGAL on Oct 19, 2007. Female patient, 66 years of age, weighting 99.21 lb, was diagnosed with rheumatoid arthritis , atrial fibrillation  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow failure, pancytopenia. Rituxan dosage: unknown. During the same period patient was treated with METHOTREXATE, FOLIC ACID, METHYLPREDNISOLONE, FUROSEMIDE, WARFARIN. Patient was hospitalized and became disabled. Patient recovered.

Rituxan Side Effects Report #4842203-8
Rituxan side effect was reported by a Physician from JAPAN on Nov 17, 2005. Female patient, 20 years of age, was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood uric acid increased, disseminated intravascular coagulation, gastrointestinal oedema, pancytopenia, sepsis , urine uric acid increased. Rituxan dosage: unknown. Patient recovered.

Rituxan Side Effects Report #4842892-8
Rituxan side effect was reported by a Physician from JAPAN on Nov 17, 2005. Female patient, 20 years of age, was treated with Rituxan. After drug was administered, patient experienced the following side effects: autoimmune disorder, blood uric acid increased, disseminated intravascular coagulation, gastrointestinal oedema, pancytopenia, sepsis . Rituxan dosage: 375 MG/M2, SINGLE, INTRAVENOUS. Patient recovered.